Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)
-
Regulation is important in the implementation of pharmacogenomics into clinical practice.
-
Regulatory pathways for pharmacogenomics are complicated and sometimes unclear, largely because they are derived from an era where genomics was a pipe dream
-
The CERSI-PGx has been working with regulators to develop proportionate, patient-focused, inclusive and forward-looking regulatory pathways to facilitate pharmacogenomics innovation and implementation.